Home » Bioanalytics » Small Molecule LC-MS/MS

Small Molecule LC-MS/MS

Global capabilities for small molecule LC-MS/MS assays.

Resolian offers key collaborations in GxP clinical and pre-clinical bioanalysis with additional full Discovery Support.

You and your team have direct access to trusted scientists and leaders across our geographies for bioanalysis of small molecular drugs using high-sensitive LC-MS/MS and ICP-MS platforms.

Projects initiate via either de novo method development or technical transfer from your scientists, followed by implementation with validation and sample analysis in compliance with regulatory guidelines to support all stages of pharmaceutical development.

Reach out to us directly to learn more about Resolian’s Small Molecule LC-MS/MS services.

Clinical and IND Enabling Support

Method development
Method transfer and optimization
GxP method validation per FDA/EMA/MHRA/ICH guidance
Cross-validation within Resolian and external partners
GLP sample analysis to support pre-clinical TK/PK studies
GCP standard sample analysis to support all phases of clinical trials
Clinical sample analysis to support bioequivalence studies

Discovery Support

Rapid method development of fit-for-purpose methods
Customized method qualification
High throughput analysis to support discovery TK/PK/PD studies and in vitro assays
Homogenization and analysis of tissues to assess drug distribution
Biomarker analysis for pre-clinical pharmacology studies